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Background
A majority of patients (85-90%) diagnosed with pancrea-
tic cancer has advanced disease at the time of diagnosis
with a dismal prognosis. Pain is a common symptom in
patients (60-90%) with advanced disease. Pain is neuro-
pathic and inflammatory, resulting from both tumour
expansion and tumour invasion of the celiac and mesen-
teric plexus. Opioids have side effects and may not be
sufficient while celiac plexus neurolysis is an invasive
procedure, despite the questionable results reported.
Currently, HIFU (high intensity focused ultrasound) an
emerging procedure completely no invasive, has been
gaining wide acceptance not only for treating neoplasm
but for symptom’s relief also.
Materials and methods
A 76 year old lady was referred to us with an advanced
head-body adenocarcinoma of the pancreas with vascu-
lar encasement of the superior mesenteric artery and
vein. She was jaundiced (bilirubin of 16 mg/dL) and
complained of back pain consistent with tumor-related
pain with a visual analogue scale (VAS) of 9/10 and
daily opioids assumption. Endoscopic placement of a
metal stent followed by HIFU treatment was considered
the best suitable option.
Results
A single step HIFU procedure was performed after an
endoscopic retrograde cholangiopancreatography (ERCP)
and biliary metallic stenting. Total treatment time was 1 h
and 50 min, with a sonication time of 60 min. Treatment
power used ranged between 400 and 150 W, although
mainly higher intensity energies were used. Total ablated
volume was 80%. No complications occurred and total
hospitalization lasted one day. Amylase and bilirubin level
showed no significant elevation in the 7 days post proce-
dure. Pain was observed at discharge with a VAS of 4/10,
while no further referred after 7 days. Patient was pain free
at first and third month with no need of oral analgesic
drugs as CT scan confirmed adequate response with
absence of perfusion on imaging. Unfortunately, due to
tumor progression patient died 4 months later.
Conclusion
Palliation has to be achieved while causing as little harm as
possible. We proved HIFU to be successful in symptoms
palliation in a patient with advanced pancreatic neoplasm.
We recommend HIFU treatment introduction and devel-
opment in several oncologic diseases, not only for thera-
peutic purposes , but also to improve patient quality of life.
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